Skip to main content
Figure 3 | BMC Psychiatry

Figure 3

From: Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results

Figure 3

Improvement from baseline in Global Assessment of Functioning (GAF) score. Scores are presented as least-squares (LS) means except for the baseline value, which is unadjusted. Patients included in this analysis were those who had a baseline and at least one follow-up assessment of their GAF score. *Changes from each visit compared with baseline (visit 1) were significant at p < .0001.

Back to article page